País: Irlanda
Língua: inglês
Origem: HPRA (Health Products Regulatory Authority)
AMOXICILLIN TRIHYDRATE CLAVULANATE POTASSIUM
Rowa Pharmaceuticals Limited
AMOXICILLIN TRIHYDRATE CLAVULANATE POTASSIUM
500/125 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
Authorised
0000-00-00
PROPOSED MOCK UP A healthy decision Sandoz Ltd, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom. T: 01276 698020 F: 01276 698324 W: www.uk.sandoz.com E: sandoz.artwork@me.com ARTWORK PROOF BOX Ref: Proof no. RA Approved? Colours: Dimensions: Date prepared: Date approved: Prepared by: Approved by: Fonts: 004.2 30/05/2012 DW 30/05/2012 VM Yes N015 - Address change, new printer Black 165 x 310 mm Helvetica Font size: 7pt Artwork/RA Checklist: Product name Strength/dosage PL number Storage Pack size Warnings Excipients Braille Co-amoxiclav is an antibiotic and works by killing bacteria that cause infections. It contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called “penicillins” that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening. Co-amoxiclav is used in adults and children to treat the following infections: • middle ear and sinus infections • respiratory tract infections • urinary tract infections • skin and soft tissue infections including dental infections • bone and joint infections. DO NOT TAKE CO-AMOXICLAV: • if you are allergic (hypersensitive) to amoxicillin, clavulanic acid, penicillin or any of the other ingredients of Co-amoxiclav (listed in section 6) • if you have ever had a severe allergic (hypersensitive) reaction to any other antibiotic. This can include a skin rash or swelling of the face or neck • if you have ever had liver problems or jaundice (yellowing of the skin) when taking an antibiotic. DO NOT TAKE CO-AMOXICLAV IF ANY OF THE ABOVE APPLY TO YOU. If you are not sure, talk to your doctor or pharmacist before taking Co-amoxiclav. TAKE SPECIAL CARE WITH CO-AMOXICLAV Talk to your doctor or pharmacist Leia o documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Co-amoxiclav 500/125mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 film-coated tablet contains: Amoxicillin 500 mg _corresponding to Amoxicillin trihydrate 574.00 mg_ Clavulanic acid 125 mg _corresponding to clavulanic acid, potassium salt 148.9mg_ For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets _Product imported from the UK:_ Off-white, oval, convex film-coated tablets scored on both sides. The tablets are 10 x 21 mm in size. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Co-amoxiclav 500/125mg Tablets is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1): Acute bacterial sinusitis (adequately diagnosed) Acute otitis media Acute exacerbations of chronic bronchitis (adequately diagnosed) Community acquired pneumonia Cystitis Pyelonephritis Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis. Bone and joint infections, in particular osteomyelitis. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component. The dose of Co-amoxiclav 500/125mg Tablets that is selected to treat an individual infection should take into account: The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4) The severity and the site of the infection The age, weight and renal function of the patient as shown below. IRISH MEDICINES BOARD _____________________________________________________________________________________________________ Leia o documento completo